Full-Time

Power Distribution and Automation Systems Engineer

Posted on 11/1/2025

Pfizer

Pfizer

10,001+ employees

Biopharmaceutical company develops medicines and vaccines

Compensation Overview

$86k - $143.3k/yr

+ Bonus target 10.0% of base salary

New City, NY, USA

In Person

Relocation assistance may be available; periodic travel may be required.

Category
Electrical Engineering (3)
, ,
Required Skills
Word/Pages/Docs
Risk Management
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • Education: Bachelor’s Degree in Electrical Engineering or equivalent work experience
  • Minimum of two years of experience: Providing expertise in the design, installation and maintenance of electrical systems specific to HVAC, purified water systems, chillers, boilers, steam, and facilities equipment
  • Minimum of two years of experience: Working in a pharmaceutical environment
  • Minimum of two years of experience: Providing engineering operations support and project management
  • Minimum of two years of experience: Working in a team environment providing critical customer service
  • Knowledge of power distribution, emergency generation and UPS power systems
  • Experience with the design and installation of laboratory and administration work areas, and facility support utility systems in a research and development environment
  • Experience with the programming of PLC control systems, HMI software, power monitoring software packages and SMART/IoT building technologies
  • Knowledge of computer network architecture and server communications
  • Working knowledge of test equipment and diagnostic instruments for automation and power distribution systems
  • Skilled with intermediate networking including the ability to diagnose ethernet and fiber hardware and interfaces
  • Possess broad analytical and problem-solving skills including some knowledge with diagnostic, test and repair techniques
  • Experience with Computerized Maintenance Management Systems
  • Ability to prepare design plans, technical reports, evaluations, and cost estimates
  • Demonstrated computer skills; Windows operating systems and databases and MS Office Suite (Outlook, Word, Excel and PowerPoint)
  • Ability to present and discuss findings with senior and first level management, colleagues, consultants, and non-company officials
  • Possess excellent written, verbal, and interpersonal skills
  • Demonstrated working knowledge of Honeywell Building Management System Software and associated hardware
  • General knowledge of the pharmaceutical industry including change management procedures
  • Project management methods, procedures, and controls
  • Demonstrated computer skills; Pfizer specific systems P2L and EAMS
  • Physical/mental requirements: Due to the nature of work assignments, incumbents must be able to perform detailed work on multiple, concurrent tasks, with frequent interruptions and under time constraints. On a daily basis, the position responsibilities may require the ability to stoop; to reach; to stand, to walk and sit for extended periods of time; to push and/or pull objects weighing up to 30 pounds; to lift and carry objects weighing up to 50 pounds with reasonable accommodation; to use finger dexterity to operate a computer and other office equipment and hand strength to grasp objects; to perceive the attributes of objects by touch; to hear and verbally exchange ideas and information with colleagues and others on the phone and in the office; to see clearly from less than one foot to arm’s length with a good field of vision and to distinguish basic colors and shades of color. On a frequent basis, essential duties of the position may require the ability to climb stairs, climb ladders, to kneel and/or crouch to retrieve items.
Responsibilities
  • Provide engineering support, assistance and oversight for facility operations and site services in regulated laboratory and office workspace environments
  • Assist with daily administration, operations, maintenance programs and projects for the following: + Primary and back-up electrical power distribution systems + Primary site automation systems including the Building Management System (BMS), Environmental Monitoring System (EMS), Security and Fire Alarm systems.
  • Assist with daily administration, operations, maintenance programs and projects for the following: + Discrete and isolated control systems associated with all facilities support and critical utility systems.
  • Provide documentation and input for near and long-term capital project planning and execution.
  • Provide automation and electrical support of both capital and expense projects for laboratory operations and facilities and site infrastructure.
  • Provide technical support as appropriate for Risk Management including but not limited to EHS, Security, Emergency Response, Business Continuity, and Compliance.
  • Provide ad-hoc engineering support and technical assistance to Digital/Business Technology in support of the site and its respective colleague groups.
  • Enhance department and organization goals by accepting ownership for accomplishing new and different requests; explore opportunities to add value to job accomplishments.
  • Update job knowledge by participating in internal and external training opportunities; internal communities of practice; maintaining personal networks; participating in professional organizations.
Desired Qualifications
  • Demonstrated working knowledge of Honeywell Building Management System Software and associated hardware
  • General knowledge of the pharmaceutical industry including change management procedures
  • Project management methods, procedures, and controls
  • Demonstrated computer skills; Pfizer specific systems P2L and EAMS

Pfizer is a global biopharmaceutical company that discovers, develops, manufactures, and sells medicines and vaccines for a range of health needs, including vaccines, oncology, and other specialized therapies. Its products work by using biological mechanisms to prevent or treat diseases—vaccines train the immune system to fight infections, while medicines target cancer and other conditions. Pfizer differentiates itself through its large worldwide footprint, broad portfolio across multiple therapeutic areas, and partnerships (notably with BioNTech) that expanded its reach in vaccines and cutting-edge therapies. The company also engages in public health initiatives, such as efforts to provide vaccines to underserved populations. Pfizer’s broad goal is to improve global health by delivering safe and effective medicines and vaccines through research, development, and wide international distribution.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1849

Simplify Jobs

Simplify's Take

What believers are saying

  • Oncology biosimilars grow 52% operationally in Q1 2026 amid high-margin expansion.
  • ELREXFIO Phase 3 data supports earlier multiple myeloma treatment positioning.
  • PF-08653944 advances to 10 Phase 3 trials in 2026 with 9.6mg dose.

What critics are saying

  • Eliquis patent expires 2028, generics erode $6B annual revenue 70% in 12 months.
  • Ibrance generics launch 2027, slash $5B sales 60-80% within 18 months.
  • Danuglipron discontinued April 2025 after liver injury in early trials.

What makes Pfizer unique

  • VEPPANU secures FDA approval as first PROTAC therapy for ESR1-mutated breast cancer.
  • VYNDAMAX patent settlements extend US exclusivity to June 2031.
  • PF-08653944 achieves 12.3% placebo-adjusted weight loss monthly in Phase 2b VESPER-3.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Relocation Assistance

Company News

Pfizer
May 4th, 2026
Esperion Therapeutics Completes $22.75 M Series A Financing | Pfizer

ANN ARBOR, Mich. & NEW YORK--(BUSINESS WIRE)--ANN ARBOR, Mich

Yahoo Finance
Apr 9th, 2026
Pfizer beats Q4 revenue estimates by 5.5% as branded pharma sector faces mixed earnings

Ten branded pharmaceuticals stocks reported mixed fourth-quarter results, with revenues missing analysts' consensus estimates by 1.7% on average. Share prices have declined 3% on average since the latest earnings results. Pfizer reported revenues of $17.56 billion, down 1.2% year-on-year but exceeding analysts' expectations by 5.5%. The stock has risen 2.8% since reporting and currently trades at $27.40. Eli Lilly delivered the strongest performance amongst peers, reporting revenues of $19.29 billion, up 42.6% year-on-year and beating expectations by 7.4%. Despite the impressive results, shares have fallen 5.2% since reporting to $951.77. The industry faces tailwinds from precision medicine advances and AI adoption, but headwinds include regulatory scrutiny, pricing pressures and patent cliffs for blockbuster drugs.

Yahoo Finance
Apr 7th, 2026
Pfizer stock seen as undervalued buy despite pipeline growth and strategic acquisitions

Pfizer, trading at less than 10 times estimated future earnings, presents significant upside potential despite recent revenue declines. The pharmaceutical company's sales fell from $101 billion in 2022 to under $63 billion last year as COVID-19 product revenues diminished. However, Pfizer has been actively preparing for growth through strategic acquisitions. In 2023, it purchased oncology specialist Seagen for $43 billion, gaining access to promising antibody-drug conjugates for cancer treatment. Last year, it acquired GLP-1 drugmaker Metsera for up to $10 billion to enter the anti-obesity drug market. The company maintains over 100 drug candidates in development. Whilst facing near-term patent cliffs on key drugs, Pfizer's extensive pipeline and low valuation suggest substantial long-term potential for investors willing to accept calculated risk.

Yahoo Finance
Apr 6th, 2026
Pfizer shares climb 7.1% in six months as organic revenue grows 10.1% annually

Pfizer shares have climbed to $28.30, delivering a 7.1% return over the past six months and outperforming the S&P 500 by 9.4 percentage points. The pharmaceutical company's organic revenue has grown at a solid 10.1% year-on-year average over the last two years, whilst its adjusted operating margin rose 17.8 percentage points to reach 35.1% for the trailing 12 months. However, Pfizer's long-term performance shows slower growth, with revenue expanding at just a 5.6% compound annual growth rate over the past five years, underperforming the broader healthcare sector. The stock currently trades at 9.6× forward price-to-earnings ratio. Founded in 1849, Pfizer develops and manufactures medicines and vaccines for various diseases and conditions globally.

Yahoo Finance
Mar 30th, 2026
Pfizer shares up 25% since Jim Cramer said 'pass' on Mad Money

Pfizer shares have risen 25% since Jim Cramer advised investors to "pass" on the stock in April 2025, citing uncertainty over potential tariffs and taxes on pharmaceutical companies. The shares are up 6.7% over the past year and 7.4% year-to-date. A notable gain occurred between 29 September and 1 October, when shares jumped 14% following Pfizer's announcement that it would lower Medicaid drug prices to match those in developing countries as part of the Trump administration's TrumpRx initiative. However, shares fell 3.3% on 3 February after the company reported fourth-quarter results of $17.6 billion in revenue and $0.66 adjusted earnings per share. Pfizer is developing a once-monthly weight loss treatment and currently offers an 8% dividend yield.

INACTIVE